Changing Trends in Uveitis in the United Kingdom: 5000 Consecutive Referrals to a Tertiary Referral Centre

References

• Fallon J, Narayan S, Lin J, Sassoon J, Llop S. The impact of polymerase chain reaction (PCR) on diagnosis and management of infectious uveitis at a tertiary care facility. J Ophthalmic Inflamm Infect. 2022;12(1):1. doi:10.1186/s12348-021-00276-w.
   PubMed Web of Science ®Google Scholar
• Rahman S, Irfan M, Siddiqui MAR. Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis -associated uveitis: a review. BMJ Open Ophthalmology. 2021;6(1):e000663. doi:10.1136/bmjophth-2020-000663.
   PubMed Web of Science ®Google Scholar
• Jones NP, Sala-Puigdollers A, Stanga PE. Ultra-widefield fundus fluorescein angiography in the diagnosis and management of retinal vasculitis. Eye. 2017;31(11):1546–1549. doi:10.1038/eye.2017.93.
   PubMed Web of Science ®Google Scholar
• Pichi F, Sarraf D, Arepalli S, et al. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res. 2017;59:178–201. doi:10.1016/j.preteyeres.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol. 1984;102:671–674. doi:10.1001/archopht.1984.01040030527008.
   PubMedGoogle Scholar
• Gass JD. Acute zonal occult outer retinopathy. J Clin Neuroophthalmol. 1993;13:79–97.
   PubMedGoogle Scholar
• Gan W-L, Jones NP. Serpiginous-like choroiditis as a marker for tuberculosis in a non-endemic area. Br J Ophthalmol. 2013;97(5):644–647. doi:10.1136/bjophthalmol-2012-302918.
   PubMed Web of Science ®Google Scholar
• Jones NP. Manchester uveitis clinic: the first 3000 patients: 1. Epidemiology and casemix. Ocul Immunol Inflamm. 2015;23:118–126. doi:10.3109/09273948.2013.855799.
   PubMed Web of Science ®Google Scholar
• Kirino Y, Ideguchi H, Takeno M, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study. Arthritis Res Ther. 2016;18(1):217. doi:10.1186/s13075-016-1115-x.
   PubMed Web of Science ®Google Scholar
• Thomas T, Chandan JS, Subramanian A, et al. Epidemiology, morbidity and mortality in Behçet’s disease: a cohort study using The Health Improvement Network (THIN). Rheumatology. 2020;59(10):2785–2795. doi:10.1093/rheumatology/keaa010.
   PubMed Web of Science ®Google Scholar
• Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138(1):46–54. doi:10.1016/j.ajo.2004.02.055.
   PubMed Web of Science ®Google Scholar
• Groen-Hakan F, van de Laar S, van der Eijk-baltissen AA, ten Dam – van Loon N, de Boer J, Rothova A. Clinical manifestations, prognosis, and vaccination status of patients with rubella virus–associated uveitis. Am J Ophthalmol. 2019;202:37–46. doi:10.1016/j.ajo.2019.02.002.
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144(3):424–428. doi:10.1016/j.ajo.2007.05.026.
   PubMed Web of Science ®Google Scholar
• Chee S-P, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of Cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883–889. doi:10.1016/j.ajo.2008.09.001.
   PubMed Web of Science ®Google Scholar
• Jones NP. Fuchs‘ heterochromic uveitis: an update. Surv Ophthalmol. 1993;37(4):253–272. doi:10.1016/0039-6257(93)90009-V.
   PubMed Web of Science ®Google Scholar
• Abu-Yaghi NE, Hartono SP, Hodge DO, Pulido JS, Bakri SJ. White dot syndromes: a 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm. 2011;19(6):426–430. doi:10.3109/09273948.2011.624287.
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259–263. doi:10.1136/bjo.84.3.259.
   PubMed Web of Science ®Google Scholar
• Anikina E, Wagner S, Liyanage S, Sullivan P, Pavesio C, Okhravi N. The risk of sympathetic ophthalmia following vitreoretinal surgery. Ophthalmol Retina. 2022;S2468-6530(22)00034–3. doi:10.1016/j.oret.2022.01.012.
   PubMedGoogle Scholar
• Doris J, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye. 2006;20(6):703–705. doi:10.1038/sj.eye.6701954.
   PubMed Web of Science ®Google Scholar
• Wells J, Wood C, Sukthankar A, Jones NP. Ocular syphilis: the re-establishment of an old disease. Eye. 2018;32(1):99–103. doi:10.1038/eye.2017.155.
   PubMed Web of Science ®Google Scholar
• Annamalai R, Mohanakumar M, Raghu K, Muthayya M. Newer trends in tubercular uveitis: a case series with systemic correlation. Int J Ophthalmol. 2020;13:1739–1744. doi:10.18240/ijo.2020.11.09.
   PubMed Web of Science ®Google Scholar
• Sanghvi C, Jones NP, Bell C, Woodhead M, Hardy C. Presumed tuberculous uveitis: diagnosis, management and outcome. Eye. 2011;25:475–480. doi:10.1038/eye.2010.235.
   PubMed Web of Science ®Google Scholar
• and the COTS-1 Study Group, Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485.
   PubMed Web of Science ®Google Scholar
• Alli HD, Ally N, Mayet I, Dangor Z, Madhi SA. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol. 2021;S0039-6257(21):00189–2.
   Google Scholar
• Kharel Sitaula R, Janani MK, Madhavan HN, Biswas J. Outcome of polymerase chain reaction (PCR) analysis in 100 suspected cases of infectious uveitis. J Ophthalmic Inflamm Infect. 2018;8(1):2. doi:10.1186/s12348-017-0144-1.
   PubMedGoogle Scholar
• Gupta V, Gupta A, Arora S, et al. Presumed tubercular serpiginouslike choroiditis. Clinical presentations and management. Ophthalmology. 2003;110(9):1744–1749. doi:10.1016/S0161-6420(03)00619-5.
   PubMed Web of Science ®Google Scholar
• Krassas N, Wells J, Bell C, Woodhead M, Jones NP. Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area. Eye. 2018;32(1):87–92. doi:10.1038/eye.2017.152.
   PubMed Web of Science ®Google Scholar
• Public Health England. Tuberculosis in North West England Annual Review (2018 Data). PHE Publications; 2020:GW–1333.
   Google Scholar
• UK Health Security Agency. Tuberculosis in England: 2021 Report. Department of Health & Social Care; 2021:GOV–10175.
   Google Scholar
• Shirley K, Dowlut S, Silvestri J, Pavesio C, Foot B. Presumed ocular tuberculosis in the United Kingdom: a British Ophthalmological Surveillance Unit (BOSU) study. Eye. 2020;34(10):1835–1841. doi:10.1038/s41433-019-0748-9.
   PubMed Web of Science ®Google Scholar
• Petrinovicc-Dorešic J, Mazuran R, Henc-Petrinović L, Kuzmanović B, Jovicić A. Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis. Ocul Immunol Inflamm. 1999;7(2):75–84. doi:10.1076/ocii.7.2.75.4017.
   PubMed Web of Science ®Google Scholar
• Ang M, Htoon HM, Chee S-P. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116(7):1391–1396. doi:10.1016/j.ophtha.2009.02.005.
   PubMed Web of Science ®Google Scholar
• Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. Br J Ophthalmol. 2016;100(10):1393–1396. doi:10.1136/bjophthalmol-2015-307455.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Sugita S, Kamoi K, Takase H. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol. 2017;61(1):1–20. doi:10.1007/s10384-016-0474-9.
   PubMed Web of Science ®Google Scholar
• Biswas J, Sitaula RK, Multani P. Changing uveitis patterns in South India - comparison between two decades. Indian J Ophthalmol. 2018;66(4):524–527. doi:10.4103/ijo.IJO_851_17.
   PubMedGoogle Scholar
• Oncul H, Kara C, Ozdal PC. Evaluation of Infectious Uveitis at a Tertiary Referral Center in Turkey: a 31-year Retrospective Study. Beyoglu Eye J. 2021;6(2):115–123. doi:10.14744/bej.2021.48726.
   PubMedGoogle Scholar
• Sonoda K-H, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H, JOIS (Japanese Ocular Inflammation Society) Uveitis Survey Working Group. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65(2):184–190. doi:10.1007/s10384-020-00809-1.
   PubMed Web of Science ®Google Scholar
• Shirahama S, Kaburaki T, Nakahara H, et al. Epidemiology of uveitis (2013–2015) and changes in the patterns of uveitis (2004–2015) in the central Tokyo area: a retrospective study. BMC Ophthalmology. 2018;18(1):189. doi:10.1186/s12886-018-0871-6.
   PubMedGoogle Scholar
• Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713
   PubMed Web of Science ®Google Scholar